BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dowd SK, Rodgers GC, Callen JP. Effective treatment with α1-protease inhibitor of chronic cutaneous vasculitis associated with α1-antitrypsin deficiency. Journal of the American Academy of Dermatology 1995;33:913-6. [DOI: 10.1016/0190-9622(95)90436-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Pirooznia N, Hasannia S, Arab SS, Lotfi AS, Ghanei M, Shali A. The design of a new truncated and engineered alpha1-antitrypsin based on theoretical studies: an antiprotease therapeutics for pulmonary diseases. Theor Biol Med Model 2013;10:36. [PMID: 23705923 DOI: 10.1186/1742-4682-10-36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Mat C, Yurdakul S, Tüzüner N, Tüzün Y. 3 Small vessel vasculitis and vasculitis confined to skin. Baillière's Clinical Rheumatology 1997;11:237-57. [DOI: 10.1016/s0950-3579(97)80045-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Blanco LE, de Serres FJ, Fernańdez-bustillo E, Kassam DA, Arbesú D, Rodríguez C, Torre JC. α1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia. Medical Hypotheses 2005;64:759-69. [DOI: 10.1016/j.mehy.2004.10.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
4 Dunlea DM, Fee LT, McEnery T, McElvaney NG, Reeves EP. The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. J Inflamm Res 2018;11:123-34. [PMID: 29618937 DOI: 10.2147/JIR.S156405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
5 Lara B. EPOC y déficit de alfa-1-antitripsina. Archivos de Bronconeumología 2010;46:2-8. [DOI: 10.1016/s0300-2896(10)70026-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
6 Bergin DA, Hurley K, McElvaney NG, Reeves EP. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz). 2012;60:81-97. [PMID: 22349104 DOI: 10.1007/s00005-012-0162-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
7 Cox N, Jorizzo JL, Bourke JF, Savage COS. Vasculitis, Neutrophilic Dermatoses and Related Disorders. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. pp. 1-95. [DOI: 10.1002/9781444317633.ch50] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis 2011;6:14. [PMID: 21486454 DOI: 10.1186/1750-1172-6-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
9 de Oliveira P, Paz-Melgar L, Takahashi MD, Nico MM, Rivitti EA, Mendrone A Jr, Tatsui NH. Alpha-1-antitrypsin deficiency associated with panniculitis treated with plasma exchange therapy. Int J Dermatol. 2004;43:693-697. [PMID: 15357756 DOI: 10.1111/j.1365-4632.2004.02054.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Bellacen K, Kalay N, Ozeri E, Shahaf G, Lewis EC. Revascularization of pancreatic islet allografts is enhanced by α-1-antitrypsin under anti-inflammatory conditions. Cell Transplant 2013;22:2119-33. [PMID: 23050776 DOI: 10.3727/096368912X657701] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
11 American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818-900. [PMID: 14522813 DOI: 10.1164/rccm.168.7.818] [Cited by in Crossref: 612] [Cited by in F6Publishing: 480] [Article Influence: 43.7] [Reference Citation Analysis]
12 Weedon D. The vasculopathic reaction pattern. Weedon's Skin Pathology. Elsevier; 2010. pp. 195-244.e49. [DOI: 10.1016/b978-0-7020-3485-5.00009-7] [Cited by in Crossref: 11] [Article Influence: 1.0] [Reference Citation Analysis]
13 Moxey JM, Low EV, Turner AM. Rare case of eosinophilic granulomatosis with polyangiitis in two patients with α-1-antitrypsin deficiency (PiSZ). BMJ Case Rep 2016;2016:bcr2015214118. [PMID: 27118743 DOI: 10.1136/bcr-2015-214118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]